Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
ALT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

21.3

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

EPS Last/This Y

0.26

EPS This/Next Y

-0.16

Price

2.6

Target Price

16.06

Analyst Recom

1.5

Performance Q

-25.43

Upside

-568.2%

Beta

0.29

Ticker: ALT




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-18ALT2.810.070.06140853
2026-05-19ALT2.730.070.07143195
2026-05-20ALT2.830.070.19144183
2026-05-21ALT2.930.070.14145215
2026-05-22ALT2.90.070.07146356
2026-05-26ALT2.930.070.22146793
2026-05-27ALT2.980.070.05148996
2026-05-28ALT3.060.070.05152997
2026-05-29ALT3.060.070.08155415
2026-06-02ALT2.90.070.21156394
2026-06-03ALT2.870.070.11156848
2026-06-04ALT2.920.070.43158528
2026-06-05ALT2.70.070.46158206
2026-06-08ALT2.730.070.06151953
2026-06-09ALT2.640.070.04153912
2026-06-10ALT2.610.070.02156870
2026-06-11ALT2.590.060.03159572
2026-06-12ALT2.610.060.06160363
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-18ALT2.817.9- -1.11
2026-05-19ALT2.747.9- -1.11
2026-05-20ALT2.837.9- -0.76
2026-05-21ALT2.937.9- -0.74
2026-05-22ALT2.9040.7- -0.74
2026-05-26ALT2.9340.7- -0.74
2026-05-27ALT2.9940.7- -0.74
2026-05-28ALT3.0640.7- -0.74
2026-05-29ALT3.0640.7- -0.74
2026-06-01ALT3.0140.7- -0.74
2026-06-02ALT2.9040.7- -0.74
2026-06-03ALT2.8740.7- -0.74
2026-06-04ALT2.9240.7- -0.74
2026-06-05ALT2.7040.7- -0.74
2026-06-08ALT2.7440.7- -0.74
2026-06-09ALT2.6440.7- -0.74
2026-06-10ALT2.6140.7- -0.74
2026-06-11ALT2.5840.7- -0.74
2026-06-12ALT2.6040.7- -0.74
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-18ALT0.5619.5519.30
2026-05-19ALT0.8419.5519.30
2026-05-20ALT0.8419.5519.30
2026-05-21ALT0.8419.5519.30
2026-05-22ALT0.8419.5519.30
2026-05-26ALT0.8416.7819.30
2026-05-27ALT0.8416.7819.30
2026-05-28ALT0.8416.7820.49
2026-05-29ALT0.8416.7820.49
2026-06-02ALT0.8416.2620.49
2026-06-03ALT0.8416.2620.49
2026-06-04ALT0.8416.2620.49
2026-06-05ALT0.8416.2620.49
2026-06-08ALT0.8416.2620.49
2026-06-09ALT0.8416.2620.49
2026-06-10ALT0.8416.2621.30
2026-06-11ALT0.8416.2621.30
2026-06-12ALT0.8416.2621.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.18

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

0.84

Institutional Transactions

16.26

Beta

0.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

29

Growth Score

23

Sentiment Score

2

Actual DrawDown %

88.9

Max Drawdown 5-Year %

-90.5

Target Price

16.06

P/E

Forward P/E

PEG

P/S

12689.49

P/B

1.2

P/Free Cash Flow

EPS

-0.94

Average EPS Est. Cur. Y​

-0.74

EPS Next Y. (Est.)

-0.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-253002.78

Relative Volume

0.56

Return on Equity vs Sector %

-59.7

Return on Equity vs Industry %

-43.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.74

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
ALT Healthcare
$2.61
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
21/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
8/10
RSI
35.4
Range 1M
7.1%
Sup Dist
1.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
30 /100
WEAK
Momentum
0/25
Growth
17/30
Estimates
0/20
Inst/Vol
5/15
Options
8/10
EPS Yr
30.9%
EPS NY
-11.1%
52W%
1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +515.3% upside
Quality
2/30
Valuation
16/30
Growth
12/25
Stability
7/10
LT Trend
1/5
Upside
+515.3%
Quality
29
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 57
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
[News_ALT _Stock]
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

ALT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

21.3

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

EPS Last/This Y

0.26

EPS This/Next Y

-0.16

Price

2.6

Target Price

16.06

Analyst Recom

1.5

Performance Q

-25.43

Upside

-568.2%

Beta

0.29

Ticker: ALT




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-18ALT2.810.070.06140853
2026-05-19ALT2.730.070.07143195
2026-05-20ALT2.830.070.19144183
2026-05-21ALT2.930.070.14145215
2026-05-22ALT2.90.070.07146356
2026-05-26ALT2.930.070.22146793
2026-05-27ALT2.980.070.05148996
2026-05-28ALT3.060.070.05152997
2026-05-29ALT3.060.070.08155415
2026-06-02ALT2.90.070.21156394
2026-06-03ALT2.870.070.11156848
2026-06-04ALT2.920.070.43158528
2026-06-05ALT2.70.070.46158206
2026-06-08ALT2.730.070.06151953
2026-06-09ALT2.640.070.04153912
2026-06-10ALT2.610.070.02156870
2026-06-11ALT2.590.060.03159572
2026-06-12ALT2.610.060.06160363
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-18ALT2.817.9- -1.11
2026-05-19ALT2.747.9- -1.11
2026-05-20ALT2.837.9- -0.76
2026-05-21ALT2.937.9- -0.74
2026-05-22ALT2.9040.7- -0.74
2026-05-26ALT2.9340.7- -0.74
2026-05-27ALT2.9940.7- -0.74
2026-05-28ALT3.0640.7- -0.74
2026-05-29ALT3.0640.7- -0.74
2026-06-01ALT3.0140.7- -0.74
2026-06-02ALT2.9040.7- -0.74
2026-06-03ALT2.8740.7- -0.74
2026-06-04ALT2.9240.7- -0.74
2026-06-05ALT2.7040.7- -0.74
2026-06-08ALT2.7440.7- -0.74
2026-06-09ALT2.6440.7- -0.74
2026-06-10ALT2.6140.7- -0.74
2026-06-11ALT2.5840.7- -0.74
2026-06-12ALT2.6040.7- -0.74
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-18ALT0.5619.5519.30
2026-05-19ALT0.8419.5519.30
2026-05-20ALT0.8419.5519.30
2026-05-21ALT0.8419.5519.30
2026-05-22ALT0.8419.5519.30
2026-05-26ALT0.8416.7819.30
2026-05-27ALT0.8416.7819.30
2026-05-28ALT0.8416.7820.49
2026-05-29ALT0.8416.7820.49
2026-06-02ALT0.8416.2620.49
2026-06-03ALT0.8416.2620.49
2026-06-04ALT0.8416.2620.49
2026-06-05ALT0.8416.2620.49
2026-06-08ALT0.8416.2620.49
2026-06-09ALT0.8416.2620.49
2026-06-10ALT0.8416.2621.30
2026-06-11ALT0.8416.2621.30
2026-06-12ALT0.8416.2621.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.18

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

0.84

Institutional Transactions

16.26

Beta

0.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

29

Growth Score

23

Sentiment Score

2

Actual DrawDown %

88.9

Max Drawdown 5-Year %

-90.5

Target Price

16.06

P/E

Forward P/E

PEG

P/S

12689.49

P/B

1.2

P/Free Cash Flow

EPS

-0.94

Average EPS Est. Cur. Y​

-0.74

EPS Next Y. (Est.)

-0.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-253002.78

Relative Volume

0.56

Return on Equity vs Sector %

-59.7

Return on Equity vs Industry %

-43.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.74

EBIT Estimation

ALT Healthcare
$2.61
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
21/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
8/10
RSI
35.4
Range 1M
7.1%
Sup Dist
1.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
30 /100
WEAK
Momentum
0/25
Growth
17/30
Estimates
0/20
Inst/Vol
5/15
Options
8/10
EPS Yr
30.9%
EPS NY
-11.1%
52W%
1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +515.3% upside
Quality
2/30
Valuation
16/30
Growth
12/25
Stability
7/10
LT Trend
1/5
Upside
+515.3%
Quality
29
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 57
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
ALT

Latest News

Caricamento notizie per ALT
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading